METTL3 and allergic asthma: While it shows protective effects in Th2-dominant allergic asthma, METTL3 may also contribute to disease exacerbation under certain inflammatory or remodeling conditions, emphasizing the need for cell type– and disease endotype–specific therapeutic targeting.